International Stem Cell Corporation

ISCO · OTC
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income$57$129-$256$11
Dep. & Amort.$56$54$55$54
Deferred Tax$0$0$0$0
Stock-Based Comp.$63$61$100$100
Change in WC$496-$647$151-$318
Other Non-Cash-$623$103$177$79
Operating Cash Flow$49-$300$227-$74
Investing Activities
PP&E Inv.-$3-$32-$5-$1
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0-$2
Investing Cash Flow-$3-$32-$5-$3
Financing Activities
Debt Repay.$0-$200$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$0-$200$0$0
Forex Effect$0$0$0$0
Net Chg. in Cash$46-$532$222-$77
Supplemental Information
Beg. Cash$920$1,452$1,230$1,307
End Cash$966$920$1,452$1,230
Free Cash Flow$46-$332$222-$77